D. E. Shaw & Co., Inc. Mimedx Group, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Mimedx Group, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 130,436 shares of MDXG stock, worth $933,921. This represents 0.0% of its overall portfolio holdings.
Number of Shares
130,436
Previous 427,129
69.46%
Holding current value
$933,921
Previous $3.75 Million
73.19%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MDXG
# of Institutions
216Shares Held
94MCall Options Held
221KPut Options Held
77.4K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$202 Million63.1% of portfolio
-
Black Rock Inc. New York, NY9.17MShares$65.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.92MShares$42.4 Million0.0% of portfolio
-
State Street Corp Boston, MA4.94MShares$35.4 Million0.0% of portfolio
-
Paradigm Capital Management Inc3.91MShares$28 Million1.46% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $813M
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...